Entelos Track Record
Entelos has a 15-year track record of partnerships with R&D organizations that have benefited from in silico R&D resources and expertise. Over 200 collaborative biosimulation engagements provided better insight, prediction of clinical outcomes, and decision-making capabilities.
Entelos combines our biosimulation resources and expertise with that of our partners to answer important R&D questions. We do this by applying Entelos PhysioLab® models, biosimulation software and expertise with partner clinical data to simulate the systems biology of virtual patients and then quantify and predict clinical outcomes.
We collaborate to build targeted models, new models, extend models with new targets and mechanisms, and create virtual patients and patient populations. Entelos technology is available to be transferred to our partner’s modeling teams.
Our solutions span the pharmaceutical R&D process for better:
- target and biomarker selection,
- species translation,
- patient stratification, and
- trial design
- custom solutions
We also have extensive experience applying our technology to consumer product R&D, in areas such as pet food, nutraceuticals and cosmeceuticals.
To learn more about our Strategic Partnerships, watch this video or Contact Us.
Learn more about the Entelos approach